Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock

Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock Bob Karr Mon, June 8, 2026 at 6:16 PM GMT+2 1 min read ABT Abbott Laboratories (NYSE: ABT ) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 27, analyst David Roman from Goldman Sachs maintained a “Buy” rating on the company’s stock and reduced the price objective to $113. 00 from $121.

00. The analyst’s rating is supported by several factors that highlight improvements in fundamentals and an attractive risk-reward profile. Notably, the analyst pointed to the clear bridge from softer early-2026 trends to healthier growth later, thanks to the accelerated sales in Nutrition, Devices, and Diagnostics, and specific product ramps like Libre and new Electrophysiology launches.

Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock Furthermore, the analyst hinted at a visible path focused on margin expansion and earnings leverage in 2026 and beyond, amid potential improvement in sentiment as execution becomes evident. While the analyst acknowledged the challenges that Abbott Laboratories (NYSE:ABT) might face in the near-term, the current valuation remains compelling relative to the company’s growth profile. Also, optional catalysts, such as favorable reimbursement decisions and share repurchases, can result in further upside, added Roman.

Abbott Laboratories (NYSE:ABT) is engaged in discovering, developing, manufacturing, and selling health care products. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock .

READ NEXT:  10 Best FMCG Stocks to Invest In According to Analysts  and  11 Best Long-Term Tech Stocks to Buy According to Analysts . Disclosure: None.   Follow Insider Monkey on Google News .